1. Home
  2. SES vs AQST Comparison

SES vs AQST Comparison

Compare SES & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SES
  • AQST
  • Stock Information
  • Founded
  • SES 2012
  • AQST 2004
  • Country
  • SES United States
  • AQST United States
  • Employees
  • SES N/A
  • AQST N/A
  • Industry
  • SES Auto Parts:O.E.M.
  • AQST Biotechnology: Pharmaceutical Preparations
  • Sector
  • SES Consumer Discretionary
  • AQST Health Care
  • Exchange
  • SES Nasdaq
  • AQST Nasdaq
  • Market Cap
  • SES 308.0M
  • AQST 272.9M
  • IPO Year
  • SES N/A
  • AQST 2018
  • Fundamental
  • Price
  • SES $0.89
  • AQST $3.74
  • Analyst Decision
  • SES Hold
  • AQST Strong Buy
  • Analyst Count
  • SES 3
  • AQST 6
  • Target Price
  • SES $1.50
  • AQST $10.67
  • AVG Volume (30 Days)
  • SES 8.5M
  • AQST 1.5M
  • Earning Date
  • SES 07-28-2025
  • AQST 08-05-2025
  • Dividend Yield
  • SES N/A
  • AQST N/A
  • EPS Growth
  • SES N/A
  • AQST N/A
  • EPS
  • SES N/A
  • AQST N/A
  • Revenue
  • SES $7,833,000.00
  • AQST $54,228,000.00
  • Revenue This Year
  • SES $916.42
  • AQST N/A
  • Revenue Next Year
  • SES $151.67
  • AQST $45.71
  • P/E Ratio
  • SES N/A
  • AQST N/A
  • Revenue Growth
  • SES N/A
  • AQST 5.29
  • 52 Week Low
  • SES $0.20
  • AQST $2.12
  • 52 Week High
  • SES $2.53
  • AQST $5.80
  • Technical
  • Relative Strength Index (RSI)
  • SES 47.79
  • AQST 68.54
  • Support Level
  • SES $0.83
  • AQST $3.13
  • Resistance Level
  • SES $0.96
  • AQST $3.33
  • Average True Range (ATR)
  • SES 0.06
  • AQST 0.22
  • MACD
  • SES -0.01
  • AQST 0.01
  • Stochastic Oscillator
  • SES 37.86
  • AQST 94.10

About SES SES AI Corporation

SES AI Corp is a developer and manufacturer of high-performance, AI-enhanced Lithium-Metal (Li-Metal) and Lithium-ion (Li-ion) rechargeable battery technologies for electric vehicles (EVs), Urban Air Mobility (UAM), drones, robotics, Battery Energy Storage Systems (BESS) and other applications. It includes Software and Hardware products that are EV, UAM, Drone, Molecular Universe, and Avatar.

About AQST Aquestive Therapeutics Inc.

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

Share on Social Networks: